Dianthus Therapeutics, Inc. (DNTH)

Dianthus Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	132.33	15.37	133.43	59.93	66.85
Short-Term Investments	41.39	60.13	45.28	90.68	80.66
Cash & Cash Equivalents	173.72	75.49	178.71	150.62	147.51
Cash Growth	130.12%	-57.76%	18.65%	2.11%	2.19%
Receivables	0.48	5.64	0	0	0
Other Current Assets	3.26	0.91	1.99	0.91	2.33
Total Current Assets	177.45	82.03	180.69	151.53	149.84
Property, Plant & Equipment	0.8	0.96	7.46	8.31	9.89
Other Long-Term Assets	1.15	0.12	1.78	1.78	1.78
Total Long-Term Assets	1.95	1.08	9.24	10.09	11.67
Total Assets	179.41	83.11	189.93	161.62	161.51
Accounts Payable	2.61	1.17	3.04	3.76	2.81
Deferred Revenue	0.84	0.89	0	0	0
Current Debt	0.42	0.35	0	0	0
Other Current Liabilities	5.77	5.82	7.82	7.67	11.3
Total Current Liabilities	9.63	8.23	10.86	11.43	14.12
Long-Term Debt	0.17	0.44	0	0	0
Other Long-Term Liabilities	0.74	0.79	6.4	6.28	6.21
Total Long-Term Liabilities	0.9	1.23	6.4	6.28	6.21
Total Liabilities	10.54	9.45	17.26	17.71	20.32
Total Debt	0.59	0.79	0	0	0
Debt Growth	-25.76%	-	-	-	-
Retained Earnings	-89.42	-45.87	-325.57	-254.43	-179.5
Comprehensive Income	0.05	-0.16	-0.03	-0.02	0.01
Shareholders' Equity	168.87	-44.37	172.67	143.91	141.19
Net Cash / Debt	173.13	74.7	178.71	150.62	147.51
Net Cash / Debt Growth	131.76%	-58.20%	18.65%	2.11%	2.19%
Net Cash Per Share	33.60	85.45	52.04	54.87	63.76
Working Capital	167.82	73.81	169.83	140.1	135.73
Book Value Per Share	32.77	-50.75	50.28	52.42	61.03

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).